Gene SCN5A function profile ��Ʈw

Taipei Medical University

Pubdiz from Gene to Disease ��] ��Ʈw

A B C D E F G H I J K L M N O P Q R X Y Z

Gene Symbol

Gene Name	Aliases	Previous_Symbol
SCN5A	sodium channel, voltage-gated, type V, alpha (long QT syndrome 3)		sodium channel, voltage-gated, type V, alpha polypeptide (long (electrocardiographic) QT syndrome 3)

View Neighborhood Gene

Result number fewer <<<< << < ALL > >> >>> more

MeSH term

Frequency	Condition_Probility
Amino Acid Sequence	10	0.0
Base Sequence	12	0.0
Child, Preschool	6	0.0
Electrocardiography	16	4.0
Humans	57	0.0
Long QT Syndrome/*genetics/therapy	2	66.0
Male	33	0.0
Molecular Sequence Data	13	0.0
Pedigree	17	0.0
Phenotype	12	0.0
*Point Mutation	3	0.0
Prognosis	2	0.0
Sodium Channels/*genetics	13	15.0
Syncope	2	100.0
Alleles	4	0.0
Animals	10	0.0
CHO Cells	2	0.0
*Cation Transport Proteins	9	4.0
Cell Line	6	0.0
*DNA-Binding Proteins	9	0.0
Electric Conductivity	2	1.0
Female	32	0.0
Gene Frequency	2	0.0
Hamsters	2	0.0
Mutation	8	0.0
Polymorphism, Genetic	4	0.0
Potassium Channels/genetics/physiology	2	50.0
*Potassium Channels, Voltage-Gated	16	6.0
Research Support, U.S. Gov't, P.H.S.	27	0.0
*Trans-Activators	9	1.0
Variation (Genetics)	2	0.0
Adult	14	0.0
Aged	4	0.0
Heart Conduction System/physiopathology	2	11.0
Middle Aged	6	0.0
Research Support, Non-U.S. Gov't	37	0.0
Syndrome	6	0.0
Action Potentials	2	3.0
Child	12	0.0
Kinetics	3	0.0
*Mutation	15	0.0
Patch-Clamp Techniques	8	2.0
Protein Structure, Tertiary	2	0.0
Sequence Homology, Amino Acid	4	0.0
Sodium Channels/chemistry/*genetics/metabolism	2	66.0
Lidocaine/pharmacology	2	18.0
Membrane Potentials/drug effects/physiology	2	2.0
Tetrodotoxin/pharmacology	2	5.0
Adolescent	8	0.0
DNA Mutational Analysis	14	0.0
Infant	3	0.0
Infant, Newborn	2	0.0
Potassium Channels/genetics	7	14.0
Sodium Channels/genetics	8	33.0
DNA/chemistry/genetics	2	0.0
Family Health	3	0.0
Mutation, Missense	6	0.0
Polymorphism, Single-Stranded Conformational	8	0.0
Sodium Channels/*genetics/physiology	3	37.0
DNA Primers	5	0.0
Genotype	10	0.0
Long QT Syndrome/*genetics	12	30.0
Adrenergic beta-Antagonists/*therapeutic use	2	5.0
Amino Acid Substitution	2	0.0
Arrhythmia/*genetics	2	25.0
*Mutation, Missense	2	0.0
Potassium Channels/*genetics	11	8.0
Sequence Analysis, DNA	2	0.0
Genetic Screening	4	0.0
Polymerase Chain Reaction	4	0.0
Electrophysiology	4	0.0
Genes, Dominant	3	0.0
*Genetic Screening	2	1.0
Mutagenesis, Site-Directed	6	0.0
*Polymorphism, Genetic	2	0.0
Research Support, U.S. Gov't, Non-P.H.S.	2	0.0
Transfection	4	0.0
Anti-Arrhythmia Agents/*therapeutic use	2	22.0
Case-Control Studies	4	0.0
Heterozygote	4	0.0
Death, Sudden, Cardiac/*etiology	3	17.0
Follow-Up Studies	2	0.0
Risk Factors	2	0.0
Exons	3	0.0
Introns	3	0.0
Cloning, Molecular	3	0.0
Xenopus	2	0.0
Cation Transport Proteins/genetics	2	12.0
Long QT Syndrome/diagnosis/*genetics	3	75.0
Chromosome Mapping	4	0.0
Gene Expression	2	0.0
Anti-Arrhythmia Agents/pharmacology	2	11.0
Linkage (Genetics)	3	0.0
Membrane Potentials	2	0.0
Point Mutation	2	0.0
Cells, Cultured	2	0.0
Xenopus laevis	2	0.0
Risk Assessment	2	0.0
Membrane Potentials/physiology	2	2.0